Detalhe da pesquisa
1.
Genetic regulation of antibody responsiveness to immunization in substrains of BALB/c mice.
Immunol Cell Biol
; 97(1): 39-53, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30152893
2.
A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy.
Nat Chem Biol
; 10(11): 943-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25282504
3.
Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
Clin Infect Dis
; 52(1): 1-7, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148512
4.
Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses.
Sci Rep
; 8(1): 15020, 2018 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301933
5.
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases.
Clin Transl Immunology
; 6(1): e125, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197336
6.
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
Tuberculosis (Edinb)
; 94(3): 226-37, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24572168
7.
Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice.
PLoS One
; 8(10): e78312, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24194918
8.
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Vaccine
; 31(7): 1026-33, 2013 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23266342
9.
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
Hum Vaccin Immunother
; 9(1): 50-62, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23143773